» Articles » PMID: 16425027

Cervical Cancer: MR Imaging Findings Before, During, and After Radiation Therapy

Overview
Journal Eur Radiol
Specialty Radiology
Date 2006 Jan 21
PMID 16425027
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, magnetic resonance (MR) imaging findings of patients with varying stages of cervical carcinoma are reviewed. The appearances of the postirradiation pelvis on MR images are also characterized and correlated with preradiation therapy staging. MR imaging findings of recurrent and metastatic disease are presented and discussed.

Citing Articles

18F-FDG PET/CT- and MRI-Based Locally Advanced Cervical Cancer Early-Response Assessment after Concurrent Chemo- and Radiotherapy-Impact on Patient Outcomes and Survival Prediction.

Lucic S, Spirovski M, Stojanovic D, Peter A, Licina J, Ivanov O Diagnostics (Basel). 2024; 14(13).

PMID: 39001322 PMC: 11241414. DOI: 10.3390/diagnostics14131432.


[Uterine Cervical Cancer: Emphasis on Revised FIGO Staging 2018 and MRI].

Jang W, Song J Taehan Yongsang Uihakhoe Chi. 2022; 82(5):1083-1102.

PMID: 36238389 PMC: 9432380. DOI: 10.3348/jksr.2021.0113.


Cervical cancer apparent diffusion coefficient values during external beam radiotherapy.

de Boer P, Mandija S, Werensteijn-Honingh A, van den Berg C, de Leeuw A, Jurgenliemk-Schulz I Phys Imaging Radiat Oncol. 2021; 9:77-82.

PMID: 33458429 PMC: 7807732. DOI: 10.1016/j.phro.2019.03.001.


Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer.

Kim N, Park W, Cho W, Bae D, Kim B, Lee J Cancer Res Treat. 2020; 53(3):803-812.

PMID: 33321566 PMC: 8291185. DOI: 10.4143/crt.2020.1251.


Cervical cancer recurrence - can we predict the type of recurrence?.

Moreira A, Cunha T, Esteves S Diagn Interv Radiol. 2020; 26(5):403-410.

PMID: 32815522 PMC: 7490029. DOI: 10.5152/dir.2020.19437.


References
1.
Ryu S, Kim M, Choi S, Choi C, Lee K . Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med. 2003; 44(3):347-52. View

2.
Keller T, Michel S, Frohlich J, Fink D, Caduff R, Marincek B . USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur Radiol. 2004; 14(6):937-44. DOI: 10.1007/s00330-004-2258-8. View

3.
Kumar R, Alavi A . PET imaging in gynecologic malignancies. Radiol Clin North Am. 2004; 42(6):1155-67, ix. DOI: 10.1016/j.rcl.2004.08.006. View

4.
Hricak H . Widespread use of MRI in gynecology: a myth or reality?. Abdom Imaging. 1997; 22(6):579-88. DOI: 10.1007/s002619900267. View

5.
Hricak H, Lacey C, Sandles L, Chang Y, Winkler M, Stern J . Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988; 166(3):623-31. DOI: 10.1148/radiology.166.3.3340756. View